Lexaria Bioscience (LEXX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lexaria Bioscience’s DehydraTECH technology has shown promising results in a 12-week diabetes animal study by outperforming the Rybelsus® control group in body weight and blood sugar control. The DehydraTECH-liraglutide and DehydraTECH-CBD formulations were particularly effective, highlighting the potential of this innovative drug delivery platform.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
